Sirona Biochem (STU:ZSB) Other Current Receivables: €0.51 Mil (As of Jul. 2024)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Sirona Biochem Other Current Receivables?

Sirona Biochem STU:ZSB Other Current Receivables is €0.51 Mil as of Jul. 2024.

Sirona Biochem's Other Current Receivables for the quarter that ended in Jul. 2024 was €0.51 Mil.

Sirona Biochem's quarterly Other Current Receivables increased from Jan. 2024 (€0.38 Mil) to Apr. 2024 (€0.46 Mil) and increased from Apr. 2024 (€0.46 Mil) to Jul. 2024 (€0.51 Mil).

Sirona Biochem's annual Other Current Receivables increased from Oct. 2021 (€0.27 Mil) to Oct. 2022 (€0.57 Mil) but then declined from Oct. 2022 (€0.57 Mil) to Oct. 2023 (€0.30 Mil).

Sirona Biochem Other Current Receivables Related Terms

Sirona Biochem Other Current Receivables Historical Data

* Premium members only.

The historical data trend for Sirona Biochem's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sirona Biochem Other Current Receivables Chart

Sirona Biochem Annual Data
Trend Oct14 Oct15 Oct16 Oct17 Oct18 Oct19 Oct20 Oct21 Oct22 Oct23
Other Current Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.27 0.25 0.27 0.57 0.30

Sirona Biochem Quarterly Data
Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24
Other Current Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.51 0.30 0.38 0.46 0.51

Sirona Biochem Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.

What does a Other Current Receivables of €0.51 Mil mean?
Sirona Biochem (STU:ZSB) has a Other Current Receivables of €0.51 Mil as of Jul. 2024. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Sirona Biochem and its competitors.
Is Sirona Biochem's Other Current Receivables too high?
Sirona Biochem's current Other Current Receivables is €0.51 Mil.
How does Sirona Biochem's Other Current Receivables compare to MTNB and TCRT?
Sirona Biochem's Other Current Receivables of €0.51 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Receivables for a Biotechnology company?
A good Other Current Receivables depends on the Biotechnology industry context. However, Other Current Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Receivables mean?
A high Other Current Receivables can signal that a stock is expensive relative to its fundamentals. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Sirona Biochem and its competitors. Sirona Biochem's current Other Current Receivables is €0.51 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sirona Biochem stock overvalued right now?
Sirona Biochem (STU:ZSB) has a current Other Current Receivables of €0.51 Mil. The current Other Current Receivables is €0.51 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Receivables calculated?
Other Current Receivables is calculated from a company's financial statements. For Sirona Biochem (STU:ZSB), the current Other Current Receivables is €0.51 Mil as of Jul. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Sirona Biochem Business Description

Address C/o WeWork, 595 Burrard Street, Vancouver, BC, CAN, V7X 1L4
Sirona Biochem Corp is a development stage biotechnology company. The principal activities of the company are the development of cosmetic and pharmaceutical active ingredients which are licensed to partners in exchange for upfront, milestone, and royalty payments. The company acts as a cosmetic ingredient and drug discovery company with a proprietary technology platform with a specialization in the stabilization of carbohydrate molecules. The company has a business presence in Canada and France.